Search clinical trials for: iloprost nebuliser solution

Total 19525 results

Shanghai Jiao Tong University School of Medicine
Cardiothoracic Surgical Group of Chinese Society of Pediatric Surgery

Completed

Multicenter Study of Iloprost Inhaled in Pulmonary Hypertension After Repair of Congenital Heart Diseases (CHD)

Pulmonary Hypertension

China
Shanghai Jiao Tong University School of Medicine

Completed

Study of Inhaled Iloprost for the Treatment of Pulmonary Hypertension After Repair of Congenital Heart Disease

Pulmonary Hypertension

China
Shanghai Jiao Tong University School of Medicine

Completed

Study of Inhaled Iloprost in Pediatric Pulmonary Hypertension (PH) After Surgery

Pulmonary Hypertension

China
Bayer

Completed

Evaluation of Inhaled Iloprost Effects Using the Breelib Nebulizer, on Clinical Outcomes and Physical Activity of Patients With Advanced Pulmonary Arterial Hypertension (VENTASTEP)

Hypertension, Pulmonary

Germany
Bayer

Completed

Comparative PK PD Study in PAH Patients (Fox vs. I-Neb)

Pulmonary Arterial Hypertension

Germany, Austria
Actelion

Completed

Inhaled Iloprost in Adults With Abnormal Pulmonary Pressure and Associated With Idiopathic Pulmonary Fibrosis

Pulmonary Fibrosis | Pulmonary Hypertension

United States
Actelion

Withdrawn

Safety and Efficacy of Inhaled Iloprost in Pediatric Patients With Pulmonary Arterial Hypertension

Pulmonary Arterial Hypertension

United States
Sultan Abdulhamid Han Training and Research Hospital...

Recruiting

Evaluation of the Efficacy of Different Nebulization Techniques

COPD Exacerbation

Turkey
University of Giessen

Completed

GM-CSF Inhalation to Prevent ARDS in COVID-19 Pneumonia (GI-COVID)

COVID-19 Pneumonia | Severe Acute Respiratory Syndrome (SARS) Pneumonia

Germany
GlaxoSmithKline

Completed

First Time in Human (FTIH) Study of GSK3008348 in Healthy Volunteers and Idiopathic Pulmonary Fibrosis Patients

Idiopathic Pulmonary Fibrosis

United Kingdom
Ludwig-Maximilians - University of Munich
Algora

Completed

Iloprost in High Risk Cardiac Surgical Patients (Ilocard)

Pulmonary Hypertension

Germany
Louisiana State University Health Sciences Center...

Completed

Inhaled Iloprost, Dynamic Hyperinflation, and Oxidative Stress in COPD Patients

Chronic Obstructive Pulmonary Disease

United States
National Cancer Institute (NCI)

Completed

Iloprost in Preventing Lung Cancer in Former Smokers

Lung Carcinoma

United States
Actelion

Terminated

Iloprost Power Disc-15 in Pulmonary Arterial Hypertension (INHALE-15)

Pulmonary Arterial Hypertension

United States
Actelion

Terminated

The "Power 15 Study": Safety Study of Inhalation of Ventavis With the Power Disc-15 Setting

Pulmonary Hypertension

United States
Actelion

Completed

Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension (PROWESS 15 Ext)

Pulmonary Arterial Hypertension

United States, Germany, Austria
Gachon University Gil Medical Center
Bayer; Seoul National University Hospital; Seoul National University Bundang... and other collaborators

Completed

Effect of BMPR-2 Gene Mutations on Hemodynamic Response by Iloprost Inhalation in Pulmonary Arterial Hypertension (PILGRIM)

Pulmonary Arterial Hypertension

Korea, Republic of
Milton S. Hershey Medical Center

Terminated

Lidocaine Administration During Flexible Bronchoscopy and Endobronchial Ultrasound

Pneumonia | Mediastinal Lymphadenopathy | Bronchiectasis Adult | Chest--Diseases | Cancer, Lung | Bronchopulmonary Disease | Infiltrates

United States
National Cancer Institute (NCI)

Withdrawn

Oral Iloprost for the Prevention of Lung Cancer In Former Smokers

Chronic Obstructive Pulmonary Disease | Lung Carcinoma | Stage II Lung Cancer AJCC v8 | Stage I Lung Cancer AJCC v8 | Tobacco-Related Carcinoma | Bronchial Epithelial Dysplasia

United States
Children's Hospital of Philadelphia

Completed

Hypertonic Saline for Acute Bronchiolitis

Saline Solution, Hypertonic | Bronchiolitis, Viral

United States
Actelion

Completed

Trial of Iloprost Inhaled Solution as Add-On Therapy With Bosentan in Subjects With Pulmonary Arterial Hypertension (PAH)

Pulmonary Arterial Hypertension | Pulmonary Hypertension | Ayerza Syndrome

United States
Bayer

Completed

Post-Marketing Surveillance of Ventavis® in Chinese Patients With Primary Pulmonary Hypertension (PPH)

Primary Hypertension

China
Imperial College London

Completed

NO Donors and Inhibitors to Study Imbalance of Nitrogen Stress and Antioxidant Defense in COPD

Chronic Obstructive Pulmonary Disease

United Kingdom
Yonsei University

Completed

Effects of Iloprost on Pulmonary Hemodynamics and Oxygenation in Patients of Chronic Obstructive Pulmonary Disease During One-lung Ventilation

Chronic Obstructive Pulmonary Disease | Video-assisted Thoracoscopic Surgery

Korea, Republic of
Heidelberg University
Bayer

Withdrawn

Iloprost for Bridging to Heart Transplantation in PH (BRIDGE)

Pulmonary Hypertension | Chronic Left Ventricular Failure

Germany
Bayer

Completed

Examination of Ventavis (Iloprost) Inhalation Behavior Using the I-Neb AAD System in Patients With Pulmonary Arterial Hypertension When Switching the Iloprost Nebulizer Solution for Inhalation From 10 μg/mL (V10) to 20 μg/mL (V20) (VENTASWITCH)

Hypertension, Pulmonary

Germany
University of Oklahoma

Completed

Iloprost in Gas Exchange/Pulm Mechanics in Chronic Obstructive Pulmonary Disease (COPD) (Iloprost)

Chronic Obstructive Pulmonary Disease | Pulmonary Hypertension

United States
Tufts Medical Center

Completed

Effectiveness of the Aeroneb in Acute Severe Asthma

Asthma Exacerbation

United States
Savara Inc.

Terminated

Trial of Inhaled Molgramostim in Cystic Fibrosis Subjects With Nontuberculous Mycobacterial Infection (ENCORE)

Mycobacterium Infections, Nontuberculous | Cystic Fibrosis (CF)

United States
Cliniques universitaires Saint-Luc- Université...

Unknown

Comparison of Lung Administration With Three Different Nebulizer

Healthy Subjects

Belgium
Hull University Teaching Hospitals NHS Trust

Completed

An Investigation Into the Mechanism of Inhalation Cough Challenge

Cough

United Kingdom
Charite University, Berlin, Germany
Schering-Plough

Terminated

Effect of Different Iloprost Doses on Symptoms in Systemic Sclerosis (ILODOSE)

Systemic Sclerosis

Germany
Loma Linda University

Withdrawn

Effects of Iloprost on Hypoxic Pulmonary Vasoconstriction at Altitude

Hypoxic Pulmonary Vasoconstriction

United States
National Center for Research Resources (NCRR)
University of Pittsburgh

Completed

Phase III Randomized, Double-Blind, Placebo-Controlled Study of Oral Iloprost for Raynaud's Phenomenon Secondary to Systemic Sclerosis

Systemic Sclerosis | Raynaud Disease
University Medical Centre Ljubljana

Terminated

The Effectiveness of Nebulized Hypertonic Saline Solution for Acute Bronchiolitis (NHSAB)

Bronchiolitis

Slovenia
Centre d'Investigation Clinique et Technologique...

Unknown

Salbutamol in the Pediatric Emergencies: Nebulization Estimated Via AerogeN or Jet (SIBILANT)

Asthma
Lund University Hospital
Bayer

Withdrawn

Treatment of Elevated Arterial Pulmonary Pressure With Inhaled Iloprost

Respiratory Distress Syndrome | Persistent Pulmonary Hypertension

Sweden
Centre Hospitalier Universitaire de Nīmes

Completed

Efficacy of the PARI LC Sprint Sp Nebulizer for Acute Asthma Attack in Hospitalized Children Less Than 36 Months of Age (LC SPRINT Sp)

Asthma

France
University of Colorado, Denver
National Cancer Institute (NCI)

Completed

Iloprost in Preventing Lung Cancer in Patients at High Risk for This Disease

Lung Cancer | Precancerous Condition

United States
Bayer

Completed

Observation of Patients With Primary Pulmonary Hypertension Receiving Prescribed Ventavis Inhalation Therapy Regarding Safety and Efficacy for up to 4 Years

Hypertension, Pulmonary

Italy, Spain, France, Germany, Portugal, United Kingdom
University of Chicago

Terminated

Inhaled Iloprost for the Treatment of Persistent Pulmonary Hypertension in the Term and Near Term Infants.

Pulmonary Hypertension

Israel, United States
Bayer

Completed

Hypertension Study of Ventavis® Inhalation Therapy in the Treatment of Patients With Pulmonary Arterial Hypertension (VENIS)

Pulmonary Hypertension

Korea, Republic of
Bayer

Completed

Safety Follow-up Study of Inhaled Iloprost in Patients With Pulmonary Hypertension

Hypertension, Pulmonary

Belgium, France, Spain, Netherlands, Italy, Portugal, Poland
National Taiwan University Hospital

Unknown

Inhaled Iloprost and Exercise Hemodynamics and Ventricular Performance in Heart Failure With Preserved Ejection Fraction (ILO-HOPE)

Heart Failure With Normal Ejection Fraction

Taiwan
Bayer

Completed

Observational Description of Compliance for the Daily Ventavis Use Via the Insight Program in Class III Pulmonary Arterial Hypertension Patients (DAILY)

Pulmonary Arterial Hypertension

France
Bayer

Completed

Aerosolized Randomized Iloprost Study II (AIR - II) Long-Term Safety, Tolerability, and Clinical Effects of Iloprost Inhalation in Patients With Primary or Secondary Pulmonary Hypertension

Hypertension, Pulmonary
Bayer

Completed

Inhaled Iloprost in the Treatment of Patients With Pulmonary Hypertension up to 4 Years (OPTION)

Pulmonary Hypertension

Turkey
Bayer

Completed

Non-interventional Study on Compliance of Inhaled Treatment With Ventavis in Patient With Pulmonary Hypertension (IVENT)

Hypertension, Pulmonary

Russian Federation
VA Loma Linda Health Care System
Actelion

Unknown

Effects of Iloprost on Hypoxic Pulmonary Vasoconstriction and Exercise Capacity at High Altitude

Hypoxic Pulmonary Vasoconstriction

United States
Christiana Care Health Services

Withdrawn

Breath Actuated Nebulizer Study Protocol

Chronic Obstructive Pulmonary Disease | Asthma

United States

3

Subscribe